Stock listing
Lang & Schwarz:A40M9J Sonoma Pharmaceuticals, Inc. Aktie
German listing (Lang & Schwarz) of Sonoma Pharmaceuticals, Inc. · home listing NASDAQ:SNOA
Follow Sonoma Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:SNOA
$1.10 USD -0.10 (-8.3%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:SNOA
- Day range
- $1.07 – $1.17 USDOct 30, 2026
- Volume
- 85,814 sharesOct 30, 2026
- Market cap
- $5.27M USDAt the close on Oct 30, 2026 · price × 4.79M shares outstanding
- 52-week range
- $0.85 – $4.01 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $135,627 USDMedian day 48,400 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SNOA · Home | $1.10 USD | -0.10 (-8.3%) | 85,814 | $1.16 | $1.17 | $1.07 | $1.20 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:SNOA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.10 | -0.10 | -8.3% | $1.16 | $1.17 | $1.07 | 85,814 | |
| $1.20 | +0.06 | +5.3% | $1.184 | $1.20 | $1.162 | 20,237 | |
| $1.14 | -0.01 | -0.9% | $1.14 | $1.18 | $1.119 | 50,626 | |
| $1.15 | +0.03 | +2.7% | $1.10 | $1.16 | $1.10 | 33,670 | |
| $1.12 | +0.01 | +0.9% | $1.12 | $1.20 | $1.10 | 62,801 | |
| $1.11 | -0.04 | -3.5% | $1.13 | $1.13 | $1.11 | 45,900 | |
| $1.15 | +0.01 | +0.9% | $1.13 | $1.17 | $1.12 | 16,900 | |
| $1.14 | -0.01 | -0.9% | $1.17 | $1.19 | $1.12 | 11,800 | |
| $1.15 | +0.03 | +2.7% | $1.16 | $1.17 | $1.13 | 10,600 | |
| $1.12 | 0.00 | 0.0% | $1.11 | $1.15 | $1.10 | 42,600 | |
| $1.12 | -0.03 | -2.6% | $1.23 | $1.23 | $1.12 | 56,900 | |
| $1.15 | -0.01 | -0.9% | $1.15 | $1.21 | $1.12 | 31,300 | |
| $1.16 | -0.02 | -1.7% | $1.16 | $1.18 | $1.13 | 49,100 | |
| $1.18 | -0.05 | -4.1% | $1.25 | $1.25 | $1.17 | 47,700 | |
| $1.23 | 0.00 | 0.0% | $1.24 | $1.29 | $1.22 | 14,800 | |
| $1.23 | +0.07 | +6.0% | $1.17 | $1.26 | $1.16 | 49,300 | |
| $1.16 | -0.06 | -4.9% | $1.20 | $1.20 | $1.14 | 89,000 | |
| $1.22 | -0.01 | -0.8% | $1.23 | $1.23 | $1.20 | 31,600 | |
| $1.23 | +0.01 | +0.8% | $1.27 | $1.27 | $1.21 | 44,700 | |
| $1.22 | -0.02 | -1.6% | $1.24 | $1.25 | $1.22 | 18,600 | |
| $1.24 | -0.01 | -0.8% | $1.28 | $1.29 | $1.22 | 27,400 | |
| $1.25 | -0.03 | -2.3% | $1.31 | $1.31 | $1.25 | 35,300 | |
| $1.28 | +0.03 | +2.4% | $1.24 | $1.30 | $1.20 | 110,700 | |
| $1.25 | -0.01 | -0.8% | $1.27 | $1.28 | $1.24 | 7,600 | |
| $1.26 | -0.01 | -0.8% | $1.29 | $1.29 | $1.24 | 30,400 | |
| $1.27 | +0.02 | +1.6% | $1.24 | $1.29 | $1.24 | 24,300 | |
| $1.25 | 0.00 | 0.0% | $1.24 | $1.29 | $1.20 | 77,700 | |
| $1.25 | -0.05 | -3.8% | $1.31 | $1.31 | $1.25 | 41,500 | |
| $1.30 | +0.05 | +4.0% | $1.27 | $1.30 | $1.26 | 14,400 | |
| $1.25 | -0.03 | -2.3% | $1.28 | $1.28 | $1.25 | 27,600 | |
| $1.28 | +0.02 | +1.6% | $1.26 | $1.34 | $1.24 | 147,400 | |
| $1.26 | +0.03 | +2.4% | $1.24 | $1.27 | $1.24 | 7,700 | |
| $1.23 | -0.05 | -3.9% | $1.28 | $1.28 | $1.23 | 106,100 | |
| $1.28 | -0.01 | -0.8% | $1.30 | $1.30 | $1.27 | 71,100 | |
| $1.29 | -0.02 | -1.5% | $1.30 | $1.30 | $1.28 | 22,100 | |
| $1.31 | 0.00 | 0.0% | $1.34 | $1.34 | $1.29 | 23,000 | |
| $1.31 | +0.01 | +0.8% | $1.30 | $1.31 | $1.29 | 32,200 | |
| $1.30 | -0.03 | -2.3% | $1.33 | $1.34 | $1.30 | 30,700 | |
| $1.33 | 0.00 | 0.0% | $1.35 | $1.36 | $1.31 | 43,500 | |
| $1.33 | +0.01 | +0.8% | $1.30 | $1.33 | $1.28 | 92,800 | |
| $1.32 | +0.03 | +2.3% | $1.30 | $1.32 | $1.29 | 47,300 | |
| $1.29 | 0.00 | 0.0% | $1.30 | $1.31 | $1.29 | 23,400 | |
| $1.29 | 0.00 | 0.0% | $1.28 | $1.31 | $1.26 | 72,500 | |
| $1.29 | -0.02 | -1.5% | $1.28 | $1.31 | $1.27 | 95,800 | |
| $1.31 | -0.02 | -1.5% | $1.33 | $1.37 | $1.28 | 92,400 | |
| $1.33 | -0.05 | -3.6% | $1.40 | $1.40 | $1.33 | 60,300 | |
| $1.38 | +0.03 | +2.2% | $1.34 | $1.41 | $1.34 | 62,400 | |
| $1.35 | +0.01 | +0.7% | $1.36 | $1.36 | $1.32 | 47,341 | |
| $1.34 | 0.00 | 0.0% | $1.33 | $1.35 | $1.32 | 63,406 | |
| $1.34 | 0.00 | 0.0% | $1.33 | $1.36 | $1.32 | 66,600 | |
| $1.34 | -0.02 | -1.5% | $1.37 | $1.38 | $1.31 | 76,000 | |
| $1.36 | +0.06 | +4.6% | $1.29 | $1.40 | $1.29 | 113,900 | |
| $1.30 | -0.02 | -1.5% | $1.31 | $1.32 | $1.29 | 50,900 | |
| $1.32 | +0.02 | +1.5% | $1.33 | $1.34 | $1.27 | 140,600 | |
| $1.30 | -0.04 | -3.0% | $1.32 | $1.37 | $1.28 | 189,700 | |
| $1.34 | -0.03 | -2.2% | $1.36 | $1.37 | $1.30 | 155,300 | |
| $1.37 | 0.00 | 0.0% | $1.39 | $1.39 | $1.31 | 101,200 | |
| $1.37 | +0.08 | +6.2% | $1.30 | $1.42 | $1.27 | 191,800 | |
| $1.29 | -0.15 | -10.4% | $1.42 | $1.43 | $1.23 | 577,400 | |
| $1.44 | +0.19 | +15.2% | $1.28 | $1.45 | $1.23 | 1,072,600 | |
| $1.25 | +0.12 | +10.6% | $1.25 | $1.30 | $1.17 | 1,529,900 | |
| $1.13 | -0.07 | -5.8% | $1.21 | $1.26 | $1.10 | 157,300 | |
| $1.20 | +0.08 | +7.1% | $1.13 | $1.24 | $1.13 | 72,700 | |
| $1.12 | +0.02 | +1.8% | $1.13 | $1.13 | $1.07 | 47,100 | |
| $1.10 | -0.03 | -2.7% | $1.12 | $1.14 | $1.10 | 28,600 | |
| $1.13 | +0.03 | +2.7% | $1.12 | $1.15 | $1.10 | 15,500 |
- Ticker
- Lang & Schwarz:A40M9J
- Asset type
- Stock
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Aug 6, 2026
Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA
Latest deck · January 2026
Investor Presentation (January 2026)
Investor deck · 30 slides
Latest news
Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA
Aug 6, 2026
Closed $1.25 (+10.6%) on Aug 6, 2026
Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution
Jun 30, 2026
Closed $1.23 (0.0%) on Jun 30, 2026
Annual Report for Fiscal Year Ending 03-31, 2026 (Form 10-K)
Jun 16, 2026
Closed $1.15 (+4.5%) on Jun 17, 2026
Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering
Apr 24, 2026
Closed $1.14 (-36.7%) on Apr 24, 2026
Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart
Mar 24, 2026
Closed $2.34 (-8.2%) on Mar 24, 2026
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin
Mar 18, 2026
Closed $2.47 (+2.9%) on Mar 18, 2026
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results
Feb 10, 2026
Closed $2.85 (+1.4%) on Feb 11, 2026
Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development
Jan 28, 2026
Closed $3.34 (-1.5%) on Jan 29, 2026
National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
Nov 13, 2025
Closed $3.54 (-3.8%) on Nov 13, 2025
Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf
Nov 6, 2025
Closed $3.68 (+0.8%) on Nov 7, 2025
Decks
Investor Presentation (January 2026)
Investor deck · 30 slides · January 2026
Investor Presentation (September 2025)
Investor deck · 30 slides · Sep 29, 2025
Investor Presentation (April 2025)
Investor deck · 31 slides · Apr 28, 2025
Investor Presentation (April 2025)
Investor deck · 31 slides · Apr 7, 2025
Sonoma Pharmaceuticals, Inc. on 6ix
- News releases
- 11 in the last 12 months · 100 in all · newest Aug 6, 2026 · oldest 2019
- Decks
- 21 decks · latest January 2026
Where Sonoma Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SNOA · Home listing | NASDAQ | United States | USD |
| BOATS:SNOA | BOATS | United States | USD |
| Lang & Schwarz:A40M9J · This page | Lang & Schwarz | Germany | EUR |
| Munich:O8Z | Munich | Germany | EUR |
| Frankfurt:O8Z | Frankfurt | Germany | EUR |
| Stuttgart:O8Z | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Sonoma Pharmaceuticals, Inc.